Q32 Bio Inc.

NASDAQ (USD): Q32 Bio Inc. (QTTB)

Last Price

3.11

Today's Change

-0.035 (1.11%)

Day's Change

3.09 - 3.22

Trading Volume

25,851

Overview

Market Cap

37 Million

Shares Outstanding

12 Million

Avg Volume

382,325

Avg Price (50 Days)

8.21

Avg Price (200 Days)

27.98

PE Ratio

-0.69

EPS

-4.51

Earnings Announcement

11-Mar-2025

Previous Close

3.15

Open

3.10

Day's Range

3.095 - 3.22

Year Range

2.9 - 53.79

Trading Volume

25,851

Price Change Highlight

1 Day Change

-1.11%

5 Day Change

-5.03%

1 Month Change

-6.74%

3 Month Change

-93.12%

6 Month Change

-90.95%

Ytd Change

-9.71%

1 Year Change

-75.06%

3 Year Change

-95.60%

5 Year Change

-99.06%

10 Year Change

-99.07%

Max Change

-99.07%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment